Kalvista Pharmaceuticals Inc (KALV) — Net Asset Quality Index
Kalvista Pharmaceuticals Inc (KALV) has a Net Asset Quality Index of 5.0% as of October 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $339.93 Million minus total liabilities of $322.93 Million yields net assets of $17.00 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Kalvista Pharmaceuticals Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Kalvista Pharmaceuticals Inc Net Asset Quality Index Over Time (2013–2025)
This chart shows how Kalvista Pharmaceuticals Inc's Net Asset Quality Index has evolved across 16 annual periods from 2013 to 2025. As of October 2025, the index stands at 5.0%, representing net assets of $17.00 Million against total assets of $339.93 Million USD. See how liquid is Kalvista Pharmaceuticals Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Kalvista Pharmaceuticals Inc (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Kalvista Pharmaceuticals Inc from 2013 to 2025, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Kalvista Pharmaceuticals Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 38.0% | $95.39 Million | $250.77 Million | $155.38 Million | ▼ -49.7 pp |
| 2024 | 87.8% | $206.58 Million | $235.40 Million | $28.82 Million | ▼ -0.1 pp |
| 2023 | 87.9% | $161.03 Million | $183.20 Million | $22.18 Million | ▼ -2.9 pp |
| 2022 | 90.8% | $185.09 Million | $203.88 Million | $18.79 Million | ▼ -3.8 pp |
| 2021 | 94.6% | $257.19 Million | $272.01 Million | $14.82 Million | ▲ +4.0 pp |
| 2020 | 90.5% | $83.75 Million | $92.53 Million | $8.78 Million | ▲ +8.6 pp |
| 2019 | 81.9% | $96.74 Million | $118.13 Million | $21.39 Million | ▲ +37.5 pp |
| 2018 | 44.4% | $27.25 Million | $61.39 Million | $34.14 Million | ▼ -46.8 pp |
| 2017 | 91.2% | $31.33 Million | $34.34 Million | $3.02 Million | ▲ +4.3 pp |
| 2016 | 86.9% | $21.50 Million | $24.75 Million | $3.25 Million | ▲ +0.2 pp |
| 2016 | 86.7% | $43.07 Million | $49.67 Million | $6.60 Million | ▼ -0.1 pp |
| 2015 | 86.8% | $49.31 Million | $56.79 Million | $7.48 Million | ▲ +751.8 pp |
| 2015 | -665.0% | $-44.18 Million | $6.64 Million | $50.83 Million | ▼ -595.4 pp |
| 2014 | -69.6% | $-4.62 Million | $6.64 Million | $11.27 Million | ▲ +264.0 pp |
| 2014 | -333.6% | $-33.71 Million | $10.11 Million | $43.81 Million | ▼ -1.9 pp |
| 2013 | -331.6% | $-28.29 Million | $8.53 Million | $36.81 Million | — |